Suven Life Sciences Shows Technical Improvement Amid Ongoing Financial Challenges
Suven Life Sciences has recently experienced a notable adjustment in its evaluation, reflecting shifts in technical indicators that suggest improved momentum. However, the company continues to face significant challenges in its financial fundamentals, including substantial operating losses and declining net sales over the past five years.
Suven Life Sciences, a small-cap player in the healthcare services sector, has recently undergone an evaluation adjustment that reflects notable shifts in its technical indicators. The stock's technical trend has transitioned, indicating a more favorable outlook based on various metrics. Key indicators such as MACD and Bollinger Bands are currently positioned in a bullish range, suggesting a positive momentum in the stock's performance.Despite the technical improvements, the company has faced challenges in its financial fundamentals. The latest quarterly results revealed a significant operating loss, contributing to a weak long-term fundamental strength. Over the past five years, net sales have contracted at an annual rate of -49.94%, and the operating profit has seen a drastic decline of -240.03%. Additionally, the company's ability to manage its debt remains a concern, with a poor EBIT to interest ratio.
Institutional investor participation has also waned, with a slight decrease in their stake over the previous quarter. This trend may reflect broader market sentiments regarding the company's financial health. Nevertheless, Suven Life Sciences has demonstrated strong market performance, generating a return of 113.65% over the past year, significantly outperforming the BSE 500 index.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
